Ferri et al. have reported increased plasma ET-1 levels in lean patients with essential hypertension, hyperlipemia and glucose intolerance compared to normotensive or subjects lacking these metabolic disorders [221]. This evidence concerns the gene EDN1 and hypertensive disorder.